Systematic review finds gut microbiota drugs reduce liver enzymes in MASLD patients compared to placebo.
New drugs targeting gut bacteria may finally treat fatty liver disease
This systematic review and network meta-analysis evaluated gut microbiota-regulating drugs, including probiotics, prebiotics, synbiotics, an…
New medicines that change gut bacteria lower liver enzymes in fatty liver patients, offering hope for those struggling with diet and exercis…
Network meta-analysis of dietary supplements for ulcerative colitis management
Some dietary supplements may help ulcerative colitis symptoms and quality of life
This network meta-analysis of 24 randomized controlled trials with 1,491 participants synthesized evidence on dietary supplements for ulcera…
A review of 24 trials found certain supplements like probiotics and flaxseed extract may ease ulcerative colitis symptoms and improve qualit…